Back to search
FDAFDA · Food and drugs·Recall number D-1060-2020

Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Pharmaceutical Associates, Inc., Greenville, SC 29605; NDC 0121-0810-16.

Published April 1, 2020 · Recall initiated: March 19, 2020

Summary

FDA records drug Class II recall D-1060-2020, published April 1, 2020 and initiated March 19, 2020. Recalling firm: PAI Holdings, LLC. dba Pharmaceutical Associates Inc; Status: Terminated; Reported quantity: 7416 bottles; Lot: Lot: BE85, Exp. 11/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

SubPotent Drug: Low out-of-specification results for assay testing.

What to do

Voluntary: Firm initiated · Letter

Get an email if NYSTATIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
NYSTATIN
Manufacturer
PAI Holdings, LLC. dba Pharmaceutical Associates Inc
Distributor
Nationwide in the USA.
UPC
0301210810022
Lot
Lot: BE85, Exp. 11/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nystatin Oral Suspension, USP, 100,000 units per mL, Cherry/Peppermint Flavor, 16 fl oz (473 mL) bottle, Rx ONLY, pai Pharmaceutical Associates, Inc., Greenville, SC 29605; NDC 0121-0810-16. recalled?

Yes. FDA published recall D-1060-2020 on April 1, 2020. Reported hazard: SubPotent Drug: Low out-of-specification results for assay testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: NYSTATIN. UPC: 0301210810022.